5 ADA 2026 Diabetes Care Updates You Should Know
Every year, diabetes care gets a little smarter, more personalized, and more focused on what can make everyday life easier for people living with…
This study is for people who are overweight or have obesity with at least one weight-related health condition and do not have Type 2 Diabetes. People with prediabetes may be eligible. The study is testing an investigational once-weekly injection to see if it is safe and effective for weight reduction. Participants will continue their current medications and receive either the study medication or a placebo.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator